Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
about
Allogeneic tumor cell vaccines: the promise and limitations in clinical trialsPhase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous MelanomaPoly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DCMurine spleen contains a diversity of myeloid and dendritic cells distinct in antigen presenting function.Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment.Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles.Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells.Purified dendritic cell-tumor fusion hybrids supplemented with non-adherent dendritic cells fraction are superior activators of antitumor immunity.In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.Lessons from cancer immunoediting in cutaneous melanoma.Generation of tumor-specific cytotoxic T-lymphocytes from the peripheral blood of colorectal cancer patients for adoptive T-cell transfer.ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells.High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function.Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapyCombining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8+ T cells.Melanoma vaccines and modulation of the immune system in the clinical setting: building from new realities.Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release.Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.Immune recognition of irradiated cancer cells.Amelioration of allergic airway inflammation in mice by regulatory IL-35 through dampening inflammatory dendritic cells.Cytokine-enhanced maturation and migration to the lymph nodes of a human dying melanoma cell-loaded dendritic cell vaccine.In Vitro Evaluation of Colloidal Silver on Immune Function: Antilymphoproliferative ActivityDissecting the Immune Stimulation Promoted by CSF-470 Vaccine Plus Adjuvants in Cutaneous Melanoma Patients: Long Term Antitumor Immunity and Short Term Release of Acute Inflammatory Reactants
P2860
Q26852333-7562D897-EBEE-4D99-9BF8-F8A8B5AEE1CFQ33741471-7977181E-4C49-47CD-B72C-DDC9D1ACF969Q33940675-D594397E-B688-46F4-BC32-AE62B2FD4736Q33985929-8DF1E853-9EF4-46CF-B1E9-0EEA8198661FQ34216915-8C9A4B5A-2F22-405E-9382-9C62EE556337Q34329143-E64139CA-6C64-4108-834B-BA96F71DA6D4Q35063621-24D1F936-3780-4979-80F3-4B8820C2526FQ35653886-50B163A8-49EF-490E-B5F2-2D804AB7EE33Q36691357-C0D3879F-B809-41E9-8176-B8AC8EC22F81Q37510538-B68B8D8B-330C-4C26-B219-39F4433C3499Q37720016-4B130F4F-614A-41ED-A157-29695993DD13Q38038176-B334E103-54B9-47EB-B1D3-F5D39932B972Q38923514-52E86B0C-3722-4DFE-8265-FB14AC9D8E60Q39023473-556C8966-84C3-4E3E-B513-CE7E65CA5CE3Q39327101-6130A6EC-44FF-4E46-82A2-067047EC3630Q39568256-1FDE29F4-47C2-4BCA-A827-6736F2BB96B9Q41205250-3B7C0C09-CA61-477F-9254-D3EB7DA41D5BQ42145973-B998CA49-B2FA-4701-987E-97DDCE7B87D3Q42976672-7BCBE994-8E3A-4413-87C8-B6E50B0C6AC3Q45369927-576BB65F-84C5-4DBE-A5BD-424BB054C0E8Q48193633-61700327-8EE6-4746-AB6D-C3CE3D8817FAQ51641181-D24343BC-C21E-4BE8-B9D8-D591B6A32E94Q53415023-ABFAE165-20E4-4943-811C-FF2C39DD6F05Q59127464-AC621A70-17F6-4107-9CC4-687D5BF24481Q59132141-D083200C-90A3-45F2-9D9F-75A24930089C
P2860
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Monocyte-derived dendritic cel ...... specific CD8(+) T lymphocytes.
@en
type
label
Monocyte-derived dendritic cel ...... specific CD8(+) T lymphocytes.
@en
prefLabel
Monocyte-derived dendritic cel ...... specific CD8(+) T lymphocytes.
@en
P2093
P2860
P356
P1476
Monocyte-derived dendritic cel ...... specific CD8(+) T lymphocytes.
@en
P2093
Cassian Yee
David Furman
Erika M von Euw
Estrella M Levy
José Mordoh
María M Barrio
Michele Bianchini
Rosa Wainstok
Yongqing Li
P2860
P2888
P356
10.1186/1479-5876-5-19
P577
2007-04-20T00:00:00Z
P5875
P6179
1045547236